Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NKT2152 |
Trade Name | |
Synonyms | NKT-2152|NKT 2152 |
Drug Descriptions |
NKT2152 binds to HIF2A and blocks DNA binding, potentially resulting in decreased target gene expression, reduced tumor cell proliferation and tumor growth inhibiton (Cancer Res 2022;82(12_Suppl):Abstract nr 6330). |
DrugClasses | HIF2A Inhibitor 6 |
CAS Registry Number | NA |
NCIT ID | C185419 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NKT2152 | NKT2152 | 0 | 1 |
NKT2152 + Palbociclib | NKT2152 Palbociclib | 0 | 1 |
NKT2152 + Palbociclib + PF-06801591 | NKT2152 PF-06801591 Palbociclib | 0 | 1 |